In summary, our study and results summarize that NNT-AS1 functions as an oncogenic lncRNA for HCC tumorigenesis through miR-363/CDK6 axis, which might be a useful diagnostic index and prognostic biomarker, providing a novel therapeutic target for human HCC. Here, CDK6 is linked to hepatocellular carcinoma.